Annual Meeting Abstract Submission Now Open
Submit an Abstract
All abstract authors will be required to submit a Financial Disclosure Statement, an FDA Disclosure Form, an Attestation and Non-Exclusive Licensing Agreement during the online submission process. ALL authors listed on an abstract will be required to submit a financial disclosure form, including disclosure of ALL financial relationships, not only those pertaining to the topic of the abstract. In the event that all authors on an abstract have not completed these required forms prior to the submission deadline of February 1, 2020 the abstract will NOT be reviewed or considered for inclusion in the Annual Meeting program.
Submitted abstracts will be reviewed and graded in blinded fashion by the Program Committee. Acceptance notification for IMAST will be made via email by May 1, 2020.
|November 1, 2019
|| Abstract Submission Site Opens
|February 1, 2020
|| Abstract Submission Deadline
|May 1, 2020
|| Annual Meeting Abstract Notification
|June 15, 2020
|| Deadline to accept presentation in program and register for Annual Meeting
All abstracts must be submitted online by Saturday, February 1, 2020. No exceptions will be made.
Abstracts with authors missing completed Conflict of Interest Disclosures will NOT be reviewed.
Adolescent Idiopathic Scoliosis
Adult Spinal Deformity
Early Onset Scoliosis
Miscellaneous Topics (Spondy, Trauma, Tumor, etc)
Non-Operative Treatment Methods